[ET Net News Agency, 8 April 2024] TIGERMED (03347) rose 10.2% to HK$30.7, breaking
above the 20-D SMA of HK$29.225.
It hits an intra-day high of HK$30.7, and an intra-day low of HK$28.6. The total shares
traded was 2.14 million, with a value of HK$61.79m. The active buy/sell ratio is 68:32,
with net buying turnover of HK$12.74m. CLSA LTD accounts for greatest net responsive
buying turnover of HK$3.51m, with volume weighted average price of HK$29.901. CHINA INV
INFO accounts for greatest net responsive selling turnover of HK$1.86m, with volume
weighted average price of HK$30.077.
Basic Information
=================
----------------------------------
Nominal 30.700 % Chg +10.23%
High 30.700 Low 28.600
Shares Tr 2.14m Turnover 61.79m
10-D SMA 29.485 %H.V 89.514
20-D SMA 29.225 VWAP 28.878
50-D SMA 27.465 RSI14 56.152
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 68:32, with net buying
turnover of HK$12.74m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
TIGERMED (03347) 30.70 +10.23
GENSCRIPT BIO (01548) 12.90 -4.73
INNOVENT BIO (01801) 36.65 +2.52
EVEREST MED-B (01952) 23.35 +6.86
WUXI BIO (02269) 13.96 +4.49
BEIGENE (06160) 91.40 +0.77
SCICLONE PHARMA (06600) 17.88 -0.45
SKB BIO-B (06990) 147.00 +6.29
AKESO (09926) 46.25 +2.55
REMEGEN (09995) 30.30 +2.89
-----------------------------------------------
(ed)